Afya Limited (NASDAQ:AFYA – Get Free Report) has received an average rating of “Moderate Buy” from the six ratings firms that are presently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $18.75.
A number of equities research analysts recently commented on AFYA shares. UBS Group upgraded shares of Afya from a “neutral” rating to a “buy” rating and dropped their price objective for the stock from $19.50 to $19.00 in a report on Monday, September 8th. JPMorgan Chase & Co. upgraded shares of Afya from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $23.50 to $24.50 in a report on Monday, September 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Wednesday, October 8th. Finally, Wall Street Zen downgraded shares of Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 20th.
View Our Latest Report on Afya
Afya Price Performance
Institutional Trading of Afya
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Militia Capital Partners LP bought a new stake in shares of Afya during the 2nd quarter worth approximately $71,000. Quantbot Technologies LP acquired a new stake in Afya in the 2nd quarter valued at about $117,000. State of Wyoming bought a new position in Afya during the second quarter worth about $164,000. Quadrature Capital Ltd bought a new stake in Afya in the second quarter valued at approximately $181,000. Finally, Van ECK Associates Corp boosted its stake in shares of Afya by 15.7% during the 3rd quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after acquiring an additional 1,377 shares during the period. Institutional investors and hedge funds own 88.02% of the company’s stock.
About Afya
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Further Reading
- Five stocks we like better than Afya
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
